Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Compass Therapeutics, Inc. (CMPX) had Normalized Income after Taxes of $-27.17M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-27.17M |
|
-- |
|
-- |
|
$28.80M |
|
$-28.80M |
|
$1.63M |
|
$-27.17M |
|
$-27.17M |
|
$-27.17M |
|
$-27.17M |
|
$-27.17M |
|
|
Normalized Income after Taxes |
$-27.17M |
$-28.80M |
|
$-28.33M |
|
186.80M |
|
186.80M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$165.50M |
|
$0.40M |
|
$9.00M |
|
$174.50M |
|
$24.37M |
|
-- |
|
$7.56M |
|
$31.93M |
|
$142.57M |
|
$142.57M |
|
$142.57M |
|
180.09M |
|
| Cash Flow Statement Financials | |
$-48.32M |
|
$55.78M |
|
$3.37M |
|
$31.21M |
|
$42.04M |
|
$10.83M |
|
$13.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-48.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.06% |
|
-19.06% |
|
-15.57% |
|
-19.06% |
|
$0.79 |
|
$-0.26 |
|
$-0.26 |
|